Active — Not RecruitingNot Applicable

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person

Canada60 participantsStarted 2023-10-01

Plain-language summary

Phase 2 randomized controlled study using a waitlist control group. The study also has a single arm pre-post test 12-week chair-based exercise arm for those who have received the geriatric assessment in the older adults with cancer clinic (geriatric oncology clinic). Study Duration 2.5 years Study Agent/ Intervention/ Procedure Comprehensive Geriatric Assessment and Management (GAM) combined with online chair-based exercise (CBE) and health education for 12 weeks.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Aged 65+ years.
✓. Diagnosed with lung, gastrointestinal (GI) , breast, Gynecologic or Genitourinary (GU) cancer or lymphoma who are referred for chemotherapy or immunotherapy and have not received \> 4 weeks of systemic treatment.
✓. Identified by the older adult as their support person.
✓. Aged 18 years and over.
✓. Able to speak and understand English.
✓. Able to give informed consent.

Exclusion criteria

✕. Severe neuropsychiatric abnormalities (e.g., moderate-severe dementia) per the treating physician; and
✕. Clinic visit with a geriatrician in the previous 12 months (they have already received part of the intervention).
✕. Chest tube in-situ.

What they're measuring

Feasability of the study

Timeframe: 12 weeks

Acceptability of the intervention and the study

Timeframe: 12 weeks

Trial details

NCT IDNCT05509751

SponsorMartine Puts

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-01

View on ClinicalTrials.gov More Lung Cancer trials